FeesSafety
Pluang+

BlackRock's BCX fund rated Buy with strong energy focus and 6.44% yield amid commodity market shifts

Market News
15 Sep 2026
Seeking Alpha
View Source
Bullish
BlackRock's BCX fund rated Buy with strong energy focus and 6.44% yield amid commodity market shifts

BlackRock Resources & Commodities Strategy Trust (BCX) is rated Buy at $12.90 due to its restructured portfolio that increases energy exposure while maintaining diversification through mining and agriculture. The fund's 6.44% forward distribution is supported by realized gains and income, with minimal capital return and strong NAV performance. Despite a 38.46% return over the past year, the portfolio changes make it well-positioned for current oil market moves. The fund's discount is near its one-year average, so future gains are expected from portfolio performance rather than discount narrowing, though risks include a broad commodity market reversal.

The BlackRock Resources & Commodities Strategy Trust (BCX) is the subject of this story. For readers following US stock market activity on Pluang, here is the market snapshot as of Sep 15, 2026 21:57 WIB: out of 150 priced US stocks, 37 rose and 111 fell. Notable movers include FUBO at USD 11.30 with a -4.80% change, PINS at USD 18.86 with a -4.22% change, and HOOD at USD 109.64 with a -4.10% change.

More News

Coca-Cola's dividend outlook strengthens while PepsiCo cuts earnings, favoring Coca-Cola for retirees.

Coca-Cola's dividend outlook strengthens while PepsiCo cuts earnings, favoring Coca-Cola for retirees.

PepsiCo recently cut its 2026 earnings outlook, while Coca-Cola raised its guidance, impacting their dividend appeal for retirees. PepsiCo offers nearly double the dividend yield at 4.13%, but Coca-Cola has a steadier payout, stronger earnings growth...

Market News
Neutral
4 hours ago
Ionis Pharmaceuticals expands revenue with new drug launches and partnerships despite cash burn.

Ionis Pharmaceuticals expands revenue with new drug launches and partnerships despite cash burn.

Ionis Pharmaceuticals is advancing its genetic medicine pipeline with new independent U.S. launches of drugs like ZANVASTRO and TRYNGOLZA, which has an expanded indication boosting revenue potential. The company also benefits from partner royalties a...

Market News
Bullish
4 hours ago
Bitcoin ETF inflows rebound with $305M net gain; Ether ETFs see $220M outflows for fourth week

Bitcoin ETF inflows rebound with $305M net gain; Ether ETFs see $220M outflows for fourth week

Spot Bitcoin ETFs saw a net inflow of about $305 million last week, recovering after two weeks of outflows. Early in the week, Bitcoin funds attracted over $1 billion before significant withdrawals on Thursday and Friday reduced gains. Meanwhile, Eth...

Market News
Neutral
4 hours ago
US markets waver as AI doubts and rising oil prices cloud Fed rate hike outlook

US markets waver as AI doubts and rising oil prices cloud Fed rate hike outlook

US markets showed volatility as concerns about the sustainability of the AI investment boom grew and oil prices surged, complicating inflation and interest rate expectations ahead of the Federal Reserve's upcoming decision. Treasury yields declined f...

Market News
Bullish
4 hours ago
Bitcoin ETFs see $138M outflows after early-week inflows reverse; Ether stabilizes, Zcash inflows continue.

Bitcoin ETFs see $138M outflows after early-week inflows reverse; Ether stabilizes, Zcash inflows continue.

Bitcoin ETFs experienced a net outflow of $137.94 million on Friday, reversing over $1 billion of inflows earlier in the week, highlighting a volatile and tactical institutional demand. Major players like Blackrock and Fidelity led both the inflows a...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App